Correction to: Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans (Hepatology, (2013), 57, 5, (1697-1704), 10.1002/hep.25990);Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans

Hepatology

Volumn 57, Issue 5, 2013, Pages 1697-1704

  Lambert, Jennifer E ^a   Bain, Vincent G ^a   Ryan, Edmond A ^a   Thomson, Alan B R ^a   Clandinin, Michael T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; D 175; DEUTERIUM; FUROSEMIDE; LACTULOSE; LINOLEIC ACID; LINOLENIC ACID; PANTOPRAZOLE; POLYUNSATURATED FATTY ACID; SPIRONOLACTONE; STABLE ISOTOPE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CANADA; CANCER PATIENT; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; FEMALE; FOOD INTAKE; GAS CHROMATOGRAPHY; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LIPID ANALYSIS; LIPID COMPOSITION; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MEAL; METABOLISM; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL; UNIVERSITY HOSPITAL; VIRUS REPLICATION; VIRUS STRAIN;

EID: 84876736533     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.31208     Document Type: Erratum

References (42)

1. Ghany MG, Strader DB, Thomas DL, Seeff LB, American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. HEPATOLOGY 2009; 49: 1335-1374.
2. Huang H, Sun F, Owen DM, Li W, Chen Y, Gale M, et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci U S A 2007; 104: 5848-5853.
3. Negro F. Abnormalities of lipid metabolism in hepatitis C virus infection. Gut 2010; 59: 1279-1287.
4. Waris G, Felmlee DJ, Negro F, Siddiqui A. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 2007; 81: 8122-8130.
5. Yang W, Hood BL, Chadwick SL, Liu S, Watkins SC, Luo G, et al. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. HEPATOLOGY 2008; 48: 1396-1403.
6. Fujino T, Nakamuta M, Yada R, Aoyagi Y, Yasutake K, Kohjima M, et al. Expression profile of lipid metabolism-associated genes in hepatitis C virus-infected human liver. Hepatol Res 2010; 40: 923-929.
7. Corey KE, Kane E, Munroe C, Barlow LL, Zheng H, Chung RT. Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. HEPATOLOGY 2009; 50: 1030-1037.
8. Diraison F, Pachiaudi C, Beylot M. Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques. J Mass Spectrom 1997; 32: 81-86.
9. Jones PJ, Leitch CA, Li ZC, Connor WE. Human cholesterol synthesis measurement using deuterated water. Theoretical and procedural considerations. Arterioscler Thromb 1993; 13: 247-253.
10. Wilke MS, French MA, Goh YK, Ryan EA, Jones PJ, Clandinin MT. Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes. Diabetologia 2009; 52: 1628-1637.
11. Pouteau E, Beysen C, Saad N, Turner S. Dynamics of adipose tissue development by 2H2O labeling. Methods Mol Biol 2009; 579: 337-358.
12. Leitch CA, Jones PJ. Measurement of triglyceride synthesis in humans using deuterium oxide and isotope ratio mass spectrometry. Biol Mass Spectrom 1991; 20: 392-396.
13. O'Meara MP, Birkenfeld LW, Gotch FA, Edelman IS. The equilibration of radiosodium (Na24), radiopotassium (K42), and deuterium oxide (D2O) in hydropic human subjects. J Clin Invest 1957; 36: 784-792.
14. Zillikens MC, van den Berg JW, Wilson JH, Rietveld T, Swart GR. The validity of bioelectrical impedance analysis in estimating total body water in patients with cirrhosis. J Hepatol 1992; 16: 59-65.
15. Nishimura M, Yamamoto H, Yoshida T, Seimiya M, Sawabe Y, Matsushita K, et al. Decreases in the serum VLDL-TG/non-VLDL-TG ratio from early stages of chronic hepatitis C: alterations in TG-rich lipoprotein levels. PLoS One 2011; 6: e17309.
16. André P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, et al. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002; 76: 6919-6928.
17. Kapadia SB, Chisari FV. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci U S A 2005; 102: 2561-2566.
18. Lerat H, Kammoun HL, Hainault I, Mérour E, Higgs MR, Callens C, et al. Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice. J Biol Chem 2009; 284: 33466-33474.
19. Nakamuta M, Yada R, Fujino T, Yada M, Higuchi N, Tanaka M, et al. Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy? Int J Mol Med 2009; 24: 825-828.
20. Schwarz JM, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 2003; 77: 43-50.
21. Parks EJ, Skokan LE, Timlin MT, Dingfelder CS. Dietary sugars stimulate fatty acid synthesis in adults. J Nutr 2008; 138: 1039-1046.
22. Ren LP, Chan SM, Zeng XY, Laybutt DR, Iseli TJ, Sun RQ, et al. Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance. PLoS One 2012; 7: e30816.
23. Bridge SH, Sheridan DA, Felmlee DJ, Nielsen SU, Thomas HC, Taylor-Robinson SD, et al. Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection. Gut 2011; 60: 680-687.
24. Yamashita T, Honda M, Takatori H, Nishino R, Minato H, Takamura H, et al. Activation of lipogenic pathway correlates with cell proliferation and poor prognosis in hepatocellular carcinoma. J Hepatol 2009; 50: 100-110.
25. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007; 7: 763-777.
26. Clandinin MT, Cheema S, Field CJ, Garg ML, Venkatraman J, Clandinin TR. Dietary fat: exogenous determination of membrane structure and cell function. FASEB J 1991; 5: 2761-2769.
27. Rysman E, Brusselmans K, Scheys K, Timmermans L, Derua R, Munck S, et al. De novo lipogenesis protects cancer cells from free radicals and chemotherapeutics by promoting membrane lipid saturation. Cancer Res 2010; 70: 8117-8126.
28. Popescu CI, Dubuisson J. Role of lipid metabolism in hepatitis C virus assembly and entry. Biol Cell 2010; 102: 63-74.
29. Ye J, Wang C, Sumpter R, Brown MS, Goldstein JL, Gale M. Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci U S A 2003; 100: 15865-15870.
30. Bader T, Fazili J, Madhoun M, Aston C, Hughes D, Rizvi S, et al. Fluvastatin inhibits hepatitis C replication in humans. Am J Gastroenterol 2008; 103: 1383-1389.
31. Economou M, Milionis H, Filis S, Baltayiannis G, Christou L, Elisaf M, et al. Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C. J Gastroenterol Hepatol 2008; 23: 586-591.
32. Cabré E, Gassull MA. Polyunsaturated fatty acid deficiency in liver diseases: pathophysiological and clinical significance. Nutrition 1996; 12: 542-548.
33. González J, Periago JL, Gil A, Cabré E, Abad-Lacruz A, Gassull MA, et al. Malnutrition-related polyunsaturated fatty acid changes in plasma lipid fractions of cirrhotic patients. Metabolism 1992; 41: 954-960.
34. Ferré N, Camps J, Prats E, Girona J, Gómez F, Heras M, et al. Impaired vitamin E status in patients with parenchymal liver cirrhosis: relationships with lipoprotein compositional alterations, nutritional factors, and oxidative susceptibility of plasma. Metabolism 2002; 51: 609-615.
35. Spritz N, Mishkel MA. Effects of dietary fats on plasma lipids and lipoproteins: an hypothesis for the lipid-lowering effect of unsaturated fatty acids. J Clin Invest 1969; 48: 78-86.
36. Hudgins LC. Effect of high-carbohydrate feeding on triglyceride and saturated fatty acid synthesis. Proc Soc Exp Biol Med 2000; 225: 178-183.
37. Sawada N, Inoue M, Iwasaki M, Sasazuki S, Shimazu T, Yamaji T, et al. Consumption of n-3 fatty acids and fish reduces risk of hepatocellular carcinoma. Gastroenterology 2012; 142: 1468-1475.
38. Davidson MH. Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol 2006; 98: 27i-33i.
39. Calder PC. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83: 1505S-1519S.
40. Murphy RA, Mourtzakis M, Chu QS, Baracos VE, Reiman T, Mazurak VC. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer 2011; 117: 1775-1782.
41. Peng S, Plank LD, McCall JL, Gillanders LK, McIlroy K, Gane EJ. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. Am J Clin Nutr 2007; 85: 1257-1266.
42. Montano-Loza AJ, Meza-Junco J, Prado CM, Lieffers JR, Baracos VE, Bain VG, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol 2012; 10: 166-73, 173.e1.